Goldberg Andrew D. (CIK 0001827722)

Latest company ownership

Shares held
3,350
Last filed at
Jun 16, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2023 Dec 19, 2023 Tarsus Pharmaceuticals, Inc. Director Buy 91.3 +1,000 50.00% ✗ $19K